Fertility Supplements

Fertility Supplements

Global Fertility Supplements Market to Reach US$3.6 Billion by 2030

The global market for Fertility Supplements estimated at US$2.5 Billion in the year 2023, is expected to reach US$3.6 Billion by 2030, growing at a CAGR of 5.4% over the analysis period 2023-2030. Synthetic & Blended Ingredients, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$2.5 Billion by the end of the analysis period. Growth in the Natural Ingredients segment is estimated at 4.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$672.3 Million While China is Forecast to Grow at 8.9% CAGR

The Fertility Supplements market in the U.S. is estimated at US$672.3 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$754.1 Million by the year 2030 trailing a CAGR of 8.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.2% and 5.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.3% CAGR.

Global Fertility Supplements Market - Key Drivers and Trends Summarized

Fertility supplements are dietary products specifically designed to support and enhance reproductive health in both men and women. These supplements typically contain a blend of vitamins, minerals, antioxidants, and herbal extracts known to play a role in hormonal balance, sperm quality, and overall reproductive function. Common ingredients include folic acid, zinc, vitamin E, coenzyme Q10, and maca root. Fertility supplements are available in various forms, such as capsules, tablets, powders, and gummies, and are often recommended by healthcare providers as part of a comprehensive approach to addressing fertility issues.

The fertility supplements market has seen significant growth and diversification in recent years, driven by increasing awareness and acceptance of natural and complementary approaches to reproductive health. A growing number of couples are turning to fertility supplements as a non-invasive alternative or adjunct to medical treatments like in vitro fertilization (IVF) and intrauterine insemination (IUI). Innovations in formulation have led to the development of targeted supplements for specific fertility issues, such as polycystic ovary syndrome (PCOS) and low sperm motility. Additionally, the rise of personalized nutrition has influenced the market, with companies offering customized supplement regimens based on individual health profiles and fertility goals.

The growth in the fertility supplements market is driven by several factors. The increasing prevalence of infertility and related conditions has heightened the demand for effective fertility-enhancing products. Secondly, advancements in nutritional science and research have supported the development of more effective and scientifically backed supplement formulations. Additionally, the expanding availability of fertility supplements through online platforms has increased consumer access and convenience. The trend towards natural and holistic health solutions has also contributed to the market`s expansion, as more individuals seek alternative and supportive treatments for fertility issues. Furthermore, demographic changes, such as delayed childbearing and a rise in the average age of first-time parents, have increased the demand for fertility supplements among older individuals trying to conceive. Finally, marketing strategies focusing on education and awareness about reproductive health have played a crucial role in driving consumer interest and adoption of fertility supplements.

Select Competitors (Total 52 Featured) -

• Active Bio Life Science GmbH
• Babystart Ltd
• Coast Science
• Crown FERTILITY
• Eu Natural, Inc.
• Exeltis USA, Inc.
• extreme V, Inc.
• Fairhaven Health
• Fertility Nutraceuticals LLC (Ovaterra)
• Gonadosan Distribution GmbH (Fertilovit)
• InnovaMed Ltd. (Amino Expert)
• Lenus Pharma GesmbH
• Orthomol pharmazeutische Vertriebs GmbH
• PlusPlus Lifesciences LLP
• Vitabiotics Ltd.
• Yadtech;

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.